Skip to main content

An employee prepares injection equipment at Insite, the legal supervised drug injection site, in Vancouver.

Rafal Gerszak/The Globe and Mail

A piece of legislation that makes it easier to open supervised injection sites has become law, replacing Harper-era regulations that effectively stalled the harm-reduction service as overdose deaths climbed.

Under Bill C-37, which received royal assent on Thursday, agencies wanting to open a supervised-injection site must meet five streamlined conditions, down from 26 under the previous Respect for Communities Act.

The Liberal government tabled the bill in December. It received final approval on Wednesday, with minor amendments.

Story continues below advertisement

Federal Health Minister Jane Philpott called the passing of the bill "very good news."

"As you well know, we're facing an overdose epidemic in this country of unprecedented proportions," she told reporters in Ottawa on Thursday.

"[The legislation] will have a significant impact in terms of our ability to offer harm-reduction services, including, of course, facilitating the ability for communities that want and need supervised consumption sites to be able to establish those facilities."

Only two new sites – both in Montreal – have been approved under the previous legislation, whose onerous process critics decried as a deliberate effort to impede supervised consumption service. The Harper government had introduced it in 2015 after fighting Insite, Vancouver's public supervised-injection site, all the way to the Supreme Court of Canada, and losing. (The Montreal sites are not yet open.)

In B.C., which has been hardest hit by the overdose crisis, a record 931 people died in 2016 alone. Provincial Health Officer Perry Kendall said energy and money that could have gone into expanding supervised consumption service instead went into fighting to keep Insite open.

"I think had the Respect for Communities Act not been in place, we might well have seen supervised consumption sites in Victoria, as well as possibly one or two more in Vancouver," he said Thursday.

"[The previous legislation] clearly acted as a disincentive for people to move forward," Dr. Kendall said.

Story continues below advertisement

Insite receives roughly 700 visits a day, including around 400 to the injection room. In 14 years of operation, it has never recorded a fatal overdose. Vancouver Coastal Health officials are hopeful the passing of Bill C-37 will mean the two applications it submitted in October will be approved soon.

The City of Vancouver estimates that at least 154 people have died so far this year.

Under the new legislation, agencies that want to open a supervised-injection site must meet five factors outlined in the 2011 Supreme Court decision regarding Insite. They must show: proof of need; community consultations; evidence about the site's effect on crime; that there is an administrative structure in place; and that there are adequate resources to maintain the site.

Only one support letter of support from the provincial or territorial minister responsible for the delivery of supervised-consumption services is now required. Previously, a prospective operator had to submit five support letters, from the minister, police, local health professionals and others. Background checks are required now only for the people in charge, not for all staff members, as per the old rules.

One proposed amendment that staff "shall offer" alternative pharmaceutical therapies before a client can use illicit drugs was changed to "may offer." Another amendment that the minister be able to establish citizen advisory committees for approved sites was deleted. The public consultation period was changed from a maximum of 90 days to a minimum of 45.

The legislation also prohibits the unregistered importation of pill presses and allows border officials to screen packages weighing 30 grams or less if there are reasonable grounds.

Story continues below advertisement

There are currently 19 outstanding applications for supervised-injection sites across Canada, with some nearing the final stages.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter